Abstract

OBJECTIVE:Hematopoietic stem-cell transplantation (HSCT) childhood survivors of hematologic malignancies are prone to develop late osteopenia and osteoporosis. The purpose of this retrospective study was to quantitatively and qualitatively assess bone mineral density (BMD) in HSCT childhood survivors and to compare the effectiveness of both qualitative and quantitative assessment methods.METHODS:DESIGN BMD assessment using panoramic radiographs of childhood HSCT survivors aged 3.69-18.88 years using two radiomorphometric indexes. Case-control double-blinded comparison of panoramic radiographic images from childhood HSCT survivors and age- and sex-matched healthy controls. Quantitative assessment was performed by measuring the cortical bone width bilaterally at the mental foramen level. Qualitative assessment was performed using the mandibular cortical index bilaterally on all panoramic images.RESULTS:Radiographs were taken 6.59-83.95 months after bone marrow transplantation [median±SD=25.92±24.9 months]. Fifty-two panoramic radiographic images were analyzed: 21 from HSCT survivors and 31 from healthy controls aged 3.69-25.1 years [mean±SD=11.89±5.28 years]. The mandibular cortical bone width was 17% smaller in childhood HSCT survivors than in healthy controls (case group: 2.420, control group: 3.307; p=0.00617). Qualitative analysis revealed an increased frequency of severe mandibular cortical erosion in childhood HSCT survivors, although no significant difference was observed (case group: 1.540, control group: 1.490; p=0.32). The interobserver agreement was 85% (Kappa index).CONCLUSIONS:HSCT childhood survivors exhibit quantitative and qualitative mandibular bone impairments. Further studies are needed to establish an association between mandibular cortical bone impairment and osteoporosis.

Highlights

  • Hematopoietic stem-cell transplantation (HSCT) plays an important role in the curative management of hematologic high-risk pediatric malignancies, with high rates of longterm disease-free survival [1,2]

  • The case (HSCT) group consisted of digital panoramic radiographic images from childhood HSCT survivors aged 3.69 to 18.88 years who were recruited at the Pediatric Oncology Institute, University of São Paulo Medical School (ITACI-ICR/FM USP), São Paulo, Brazil

  • The HSCT type was autogenous in 29% of patients, allogenic in 58% of patients, and umbilical cord in 21% of cases

Read more

Summary

Introduction

Hematopoietic stem-cell transplantation (HSCT) plays an important role in the curative management of hematologic high-risk pediatric malignancies, with high rates of longterm disease-free survival [1,2]. Received for publication on September 2, 2018. Accepted for publication on February 27, 2019. Dual-energy X-ray absorptiometry (DXA) of long bones or vertebrae is the preferred method for the diagnosis of low BMD. DXA is well established as the gold standard examination for diagnosing osteopenia/osteoporosis, as recommended by the World Health Organization (WHO) [6]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.